-
Plenary highlights the benefits and challenges of international clinical trials
Experts outline the nuanced dynamics of international research, including the role of health technology assessment and real-world evidence in decision-making, in an opening-day plenary.
-
Linking clinical data and biospecimens drives translational research
Experts including Jill Hollenbach, PhD, MPH, detailed new developments in clinically impactful translational research.
-
Session explores proactive financial navigation to address clinical trial barriers
Warren Fingrut, MD, outlined a project to evaluate proactive financial navigation for patients with aplastic anemia.
-
Panel will examine considerations of age in identifying optimal donors
Stephen Spellman, MBS, previews this session on recent age-focused research that has the potential to guide future studies and decisions in characterizing the optimal suitability of donors.
-
ACCESS Initiative will review its work targeting barriers to care and outcomes
Jeffery J. Auletta, MD, explains what to expect when members of the ASTCT® and NMDP℠ ACCESS Initiative discuss their work to identify and dismantle access and outcome barriers to HCT and cellular therapy.
-
Oral abstract session to highlight novel GVHD strategies
The four oral abstract sessions on the agenda for Feb.13 are among more than a dozen oral abstract sessions included in this year’s program.
-
Meet the abstract presenter: Noha Sharafeldin, MD, MSc, PhD
Noha Sharafeldin, MD, MSc, PhD, will present one of the abstracts featured in the Best Abstracts session on Friday during the Tandem Meetings.
-
Meet the abstract presenter: Parmeshwar Amatya, PhD, MPH
Parmeshwar Amatya, PhD, MPH, will present one of the abstracts featured in the Best Abstracts session on Friday during the Tandem Meetings.